03Oct/13

Cellmid's midkine antibodies show effectiveness against cancer – Proactive Investors Chinese


Proactive Investors Chinese

Cellmid’s midkine antibodies show effectiveness against cancer
Proactive Investors Chinese
Cellmid Limited (ASX: CDY) has completed several studies that demonstrate its lead anti-midkine (MK) antibodies efficacy in reducing cancer tumour growth and spread. The antibodies also slowed the formation of new blood vessels (angiogenesis) in 

and more »